Catalyst
Slingshot members are tracking this event:
SAGE Top-Line Phase 3 Data Evaluating SAGE-547 in Moderate and Severe Postpartum Depression due H2 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 09, 2017
Occurred Source:
http://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-announces-brexanolone-achieves-primary
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Top-line, Phase 3, Sage-547, Postpartum Depression
